SENSEX NIFTY

Novo Nordisk

Apr 26, 2016 at 18:54 | Source: PTI
Haemophilia is a chronic, inherited bleeding disorder that primarily affects males. People with haemophilia A are either missing or have a malfunctioning factor VIII protein, which is essential for proper blood clotting.
Jul 17, 2015 at 09:49 | Source: Moneycontrol.com
The pharma major has received an approval from the USFDA for PrandiMet (also known as Prandin) generic that is used for treatment of type 2 diabetes.
Oct 09, 2013 at 13:00 | Source: Reuters
The concept of oral insulin as a way to relieve people with type 1 diabetes of several daily injections has been around since the 1930s.
Sep 03, 2013 at 21:14 | Source: CNBC-TV18
Danish drug maker Novo Nordisk is all set to launch its ultra long-lasting insulin injection, brand named Tresiba, in India by the end of this year.
Feb 14, 2013 at 10:18 | Source: Moneycontrol.com
Biocon shares rose 2 percent in morning trade on Thursday after the biotechnology company said it has enhanced its partnership with pharma major Mylan through a strategic collaboration for insulin products.
Apr 18, 2012 at 14:20 | Source: Moneycontrol.com
Shares of pharma major Sun Pharmaceutical Industries rose over 2.5% on Wednesday, after US Supreme Court gave a verdict in favour of its arm Caraco Pharmaceutical Laboratories in the ongoing battle with Novo Nordisk for a generic version of diabetic drug Prandin.
Apr 17, 2012 at 20:36 | Source: Reuters
The US Supreme Court ruled on Tuesday in favor of a generic drugmaker in a case over how companies can fight brand-name rivals in an effort to get their cheaper medicines to market.
Apr 16, 2012 at 18:54 | Source: CNBC-TV18
Novo Nordisk, in association with CNBC-TV18, presents "Improving Control of Diabetes Pandemic in India". In this discussion, experts address the challenges and management of diabetes in India.
Mar 20, 2012 at 21:43 | Source: CNBC-TV18
Multi-national drug companies are queuing up to enter India and tap its growing anti-diabetes drug market. But Novo Nordisk, which has been in the Indian insulin market for 75 years, is not worried, reports CNBC-TV18's Archana Shukla.
Mar 13, 2012 at 10:30 | Source: Moneycontrol.com
Pfizer - Biocon alliance has called off due to individual priorities and in Shares of Biocon fell more than 8% on Tuesday morning after US pharma major Pfizer scrapped a deal to sell insulin products made by the Bangalore-based biotechnology company.
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.